Denali Therapeutics Inc. (24) | Sales Agreements (6)
Recent Contracts
-
Amendment No. 7 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated March 29, 2021
(Filed With SEC on February 27, 2023)
-
Amendment No. 8 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 8, 2022
(Filed With SEC on February 27, 2023)
-
Amendment No. 9 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated December 7, 2022
(Filed With SEC on February 27, 2023)
-
Amendment No. 5 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October...
(Filed With SEC on February 26, 2021)
-
Amendment No. 3 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October...
(Filed With SEC on February 26, 2021)
-
Amendment No. 6 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October...
(Filed With SEC on February 26, 2021)